Induction of Prostacyclin/PGI2 Synthase Expression After Cerebral Ischemia–Reperfusion
Open Access
- 1 April 2006
- journal article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 26 (4) , 491-501
Abstract
Prostacyclin (PGI2), a potent vasodilator and inhibitor of platelet aggregation and leukocyte activation, is crucial in vascular diseases such as stroke. Prostacyclin synthase (PGIS) is the key enzyme for PGI2 synthesis. Although expression of PGIS was noted in the brain, its role in ischemic insult remains unclear. Here we reported the temporal and spatial expression of PGIS mRNA and protein after 60-min transient ischemia. Northern blot and in situ hybridization revealed a delayed increase of PGIS mRNA in the ischemic cortex at 24- to 72-h after ischemia; PGIS was detected mainly in the ipsilateral penumbra area, pyriform cortex, hippocampus, and leptomeninges. Western blot and immunohistochemical analysis revealed that PGIS proteins were expressed temporally and spatially similar to PGIS mRNA. PGIS was heavily colocalized with PECAM-1 to endothelial cells at the leptomeninges, large and small vessels, and localized to neuronal cells, largely at the penumbra area. A substantial amount of PGIS was also detected in the macrophage and glial cells. To evaluate its role against ischemic infarct, we overexpressed PGIS by adenoviral gene transfer. When infused 72 h before ischemia (–72 h), Adv-PGIS reduced infarct volume by ~50%. However, it had no effect on infarct volume when infused immediately after ischemia (0 h). Eicosanoid analysis revealed selective elevation of PGI2 at −72 h while PGI2 and TXB2 were both elevated at 0 h, altering the PGI2/thromboxane A2 (TXA2) ratio from 10 to 4. These findings indicate that PGIS protects the brain by enhancing PGI2 synthesis and creating a favorable PGI2/TXA2 ratio.Keywords
This publication has 28 references indexed in Scilit:
- Dynamic Changes in Cerebral Blood Flow and Angiogenesis After Transient Focal Cerebral Ischemia in RatsStroke, 2002
- Cyclooxygenase-1 and Bicistronic Cyclooxygenase-1/Prostacyclin Synthase Gene Transfer Protect Against Ischemic Cerebral InfarctionCirculation, 2002
- Induction of Angiopoietin and Tie Receptor mRNA Expression after Cerebral Ischemia–ReperfusionJournal of Cerebral Blood Flow & Metabolism, 2000
- Organization of the Gene Encoding Human Prostacyclin SynthaseBiochemical and Biophysical Research Communications, 1996
- Neuroprotective Effect of TTC-909, an Isocarbacyclin Methyl Ester Incorporated in Lipid Microspheres, on Hippocampal Delayed Neuronal Death of Stroke-Prone Spontaneously Hypertensive RatsThe Japanese Journal of Pharmacology, 1996
- Effect of brain edema on infarct volume in a focal cerebral ischemia model in rats.Stroke, 1993
- Arachidonic Acid and Its Metabolites in Cerebral IschemiaaAnnals of the New York Academy of Sciences, 1989
- Double-blind controlled trial of prostacyclin in cerebral infarction.Stroke, 1985
- Biology and therapeutic potential of prostacyclin.Stroke, 1983
- Effects of ischemia and electroconvulsive shock on free fatty acid pool in the brainBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1970